Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland
在瑞士，voretigene neparvovec 治疗携带 RPE65 突变的遗传性视网膜疾病患者的成本效益分析
期刊:BMC Health Services Research
影响因子:
doi:10.1186/s12913-022-08211-y
Bhadhuri, Arjun; Dröschel, Daniel; Guldimann, Mike; Jetschgo, Claudia; Banhazi, Judit; Schwenkglenks, Matthias; Sutherland, C Simone
